European Society for Contraception Annual Conference

Gynuity staff members and colleagues gave presentations reporting on and results from several medical abortion studies conducted in Georgia, Tunisia, United States and Ukraine.

A Comparison of Two Dosages of Buccal Misoprostol Following Mifepristone for Early Medical Abortion
T. Tsereteli, E. Chong, G. Tsertsvadze, G. Tevdorashvili, N. Manjgaladze, B. Winikoff

Expanding Options for in-the-Mouth Misoprostol Administration Following Mifepristone in Medical Abortion
I. Dzuba, M. Creinin, W. Crowden, A. Goldberg, J. Gonzales, M. Howe, E.S. Lichtenberg, J. Moskowitz, L. Prine, C. Shannon, B. Winikoff

Introducing a Reduced 200 mg Dose of Mifepristone followed by Misoprostol for Medical Abortion through 56 Days Gestation in Ukraine
S. Raghavan, V. Lishchuk, S. Zhuk, S. Posohova, G. Maistruk, V. Bannikov, B. Winikoff

Ten Years of Medical Abortion Services and Innovations in Tunisia
S. Hajri, R. Ben Aissa, R. Dabash, H. Chelli, D. Halleb, N. Gueddana, B. Winikoff